mirror of
https://github.com/msberends/AMR.git
synced 2025-09-15 15:09:41 +02:00
Built site for AMR@3.0.0.9029: c7b2acb
This commit is contained in:
@@ -9,7 +9,7 @@ Adhering to previously described approaches (see Source) and especially the Baye
|
||||
|
||||
<a class="navbar-brand me-2" href="../index.html">AMR (for R)</a>
|
||||
|
||||
<small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">3.0.0.9021</small>
|
||||
<small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">3.0.0.9029</small>
|
||||
|
||||
|
||||
<button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
|
||||
@@ -587,9 +587,9 @@ Adhering to previously described approaches (see Source) and especially the Baye
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #949494;"># Type: WISCA with 95% CI</span></span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> `Syndromic Group` `Piperacillin/tazobactam` Piperacillin/tazobactam + Gentam…¹</span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #949494; font-style: italic;"><chr></span> <span style="color: #949494; font-style: italic;"><chr></span> <span style="color: #949494; font-style: italic;"><chr></span> </span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #BCBCBC;">1</span> Clinical 73.6% (68.3-78.8%) 92.3% (90.8-93.8%) </span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #BCBCBC;">2</span> ICU 57.2% (49.8-65.1%) 84.9% (81.8-87.8%) </span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #BCBCBC;">3</span> Outpatient 57.1% (47.2-66.8%) 74.4% (69-79.6%) </span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #BCBCBC;">1</span> Clinical 73.4% (67.6-78.6%) 92.4% (90.6-93.7%) </span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #BCBCBC;">2</span> ICU 57.4% (49.7-65.6%) 85% (82.1-87.6%) </span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #BCBCBC;">3</span> Outpatient 56.9% (46.9-66.7%) 74.4% (69-79.7%) </span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #949494;"># ℹ abbreviated name: ¹`Piperacillin/tazobactam + Gentamicin`</span></span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #949494;"># ℹ 1 more variable: `Piperacillin/tazobactam + Tobramycin` <chr></span></span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> <span style="color: #949494;"># Use `ggplot2::autoplot()` or base R `plot()` to create a plot of this antibiogram,</span></span>
|
||||
@@ -614,9 +614,9 @@ Adhering to previously described approaches (see Source) and especially the Baye
|
||||
<span class="r-out co"><span class="r-pr">#></span> </span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> |Syndromic Group |Piperacillin/tazobactam |</span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> |:---------------|:-----------------------|</span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> |Clinical |73.4% (67.8-78.8%) |</span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> |ICU |57.2% (49.6-65.3%) |</span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> |Outpatient |56.9% (47.1-66.9%) |</span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> |Clinical |73.6% (68.4-79%) |</span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> |ICU |57.4% (49.7-65.4%) |</span>
|
||||
<span class="r-out co"><span class="r-pr">#></span> |Outpatient |57% (47.2-66.7%) |</span>
|
||||
<span class="r-in"><span></span></span>
|
||||
<span class="r-in"><span></span></span>
|
||||
<span class="r-in"><span><span class="co"># Generate plots with ggplot2 or base R --------------------------------</span></span></span>
|
||||
|
Reference in New Issue
Block a user